ACS
In Brief This Week: Bruker; BD; Immunovia; American Cancer Society, Color Health
News items for the week of April 29, 2024.
Studies Outline Outcomes Associated With Cervical Cancer Screening, Triage Strategies
A pair of new studies evaluated the effectiveness of cytologic and HPV-based testing approaches at varied screening intervals for identifying women at risk of cervical cancer.
American Cancer Society Philanthropic Fund BrightEdge Invests in Castle Bio
BrightEdge was founded by the American Cancer Society to invest in for-profit companies developing novel cancer therapeutics and diagnostics.
Exact Sciences Shares Rise Sharply on New Colorectal Cancer Screening Recommendation
The American Cancer Society today lowered the recommended age for screening patients at average risk for the disease to 45 from 50 years old.
Lab Industry Reacts to USPSTF Recommendation Against Cervical Cancer Co-testing
With only one test FDA-approved for primary hrHPV screening, groups express concern about feasibility of moving away from co-testing